SCHEMBL7226348

SCHEMBL7226348

COc1cc(N(C(=O)c2c(-c3c(F)cccc3I)noc2C)c2cccc(NC(C)=O)c2)cc(OC)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.45
LMNA P02545 3/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GHSR Q92847 1/20 0.41
ALOX12 P18054 1/20 0.41
GLA P06280 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GPBAR1 Q8TDU6 1/20 0.39
KDM4E B2RXH2 1/20 0.38
BRAF P15056 3/20 0.38
FYN P06241 1/20 0.37
EPAS1 Q99814 1/20 0.37
PAX8 Q06710 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776886 0.94 PTGS2 (0.49) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL5774936 0.88 PTGS2 (0.42) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL5778310 0.86 POLB (0.51) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL5777332 0.84 PTGS2 (0.42) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL5774719 0.81 PTGS2 (0.48) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL5776661 0.78 PTGS2 (0.45) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL5773623 0.77 EPAS1 (0.58) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL7226352 0.75 PTGS2 (0.58) PTGS2LMNAHPGDSMN1; SMN2GHSR
SCHEMBL5774424 0.75 POLB (0.46) PTGS2LMNAALDH1A1HPGDTSHR
SCHEMBL6696053 0.74 PTGS2 (0.35) PTGS2LMNAALDH1A1SMN1; SMN2GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670373-B1 Inhibiting resistant neoplasms where the resistance is conferred by multidrug resistance protein; N-3,4,5-trimethoxyphenyl-3-(3-azidomethyl-isoxazolo(4,5-c) -1,2-dihydro-6-chloro-quinolin-2-on-1-yl)phenylacetamide ELI LILLY AND COMPANY 2003-12-30 US disclosed
EP-1224189-A2 CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2002-07-24 EP disclosed
WO-2001027116-A2 CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2001-04-19 WO disclosed